Michael Landsittel's most recent trade in Blueprint Medicines Corp was a trade of 5,284 Common Stock done at an average price of $88.8 . Disclosure was reported to the exchange on March 5, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Blueprint Medicines Corp | Michael Landsittel | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 88.80 per share. | 05 Mar 2025 | 5,284 | 72,924 (0%) | 0% | 88.8 | 469,219 | Common Stock |
| Blueprint Medicines Corp | Michael Landsittel | CHIEF FINANCIAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2025 | 22,000 | 22,000 | - | - | Stock Option (Right to Buy) | |
| Blueprint Medicines Corp | Michael Landsittel | CHIEF FINANCIAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2025 | 11,000 | 78,208 (0%) | 0% | 0 | Common Stock | |
| Blueprint Medicines Corp | Michael Landsittel | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 95.23 per share. | 15 Aug 2024 | 4,409 | 67,208 (0%) | 0% | 95.2 | 419,869 | Common Stock |
| Blueprint Medicines Corp | Michael Landsittel | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 107.17 per share. | 15 May 2024 | 2,486 | 72,981 (0%) | 0% | 107.2 | 266,425 | Common Stock |
| Blueprint Medicines Corp | Michael Landsittel | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 106.56 per share. | 15 May 2024 | 1,364 | 71,617 (0%) | 0% | 106.6 | 145,348 | Common Stock |
| Blueprint Medicines Corp | Michael Landsittel | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 May 2024 | 26,363 | 0 | - | - | Stock Option (Right to Buy) | |
| Blueprint Medicines Corp | Michael Landsittel | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.87 per share. | 08 May 2024 | 26,363 | 73,649 (0%) | 0% | 1.9 | 49,299 | Common Stock |
| Blueprint Medicines Corp | Michael Landsittel | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 8.80 per share. | 08 May 2024 | 1,818 | 75,467 (0%) | 0% | 8.8 | 15,998 | Common Stock |
| Blueprint Medicines Corp | Michael Landsittel | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 May 2024 | 1,818 | 0 | - | - | Stock Option (Right to Buy) | |
| Blueprint Medicines Corp | Michael Landsittel | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 May 2024 | 10,000 | 0 | - | - | Stock Option (Right to Buy) | |
| Blueprint Medicines Corp | Michael Landsittel | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 105.00 per share. | 02 May 2024 | 10,000 | 47,286 (0%) | 0% | 105 | 1,050,000 | Common Stock |
| Blueprint Medicines Corp | Michael Landsittel | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 36.05 per share. | 02 May 2024 | 10,000 | 57,286 (0%) | 0% | 36.1 | 360,500 | Common Stock |
| Blueprint Medicines Corp | Michael Landsittel | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 36.05 per share. | 28 Mar 2024 | 5,000 | 52,286 (0%) | 0% | 36.1 | 180,250 | Common Stock |
| Blueprint Medicines Corp | Michael Landsittel | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Mar 2024 | 5,000 | 10,000 | - | - | Stock Option (Right to Buy) | |
| Blueprint Medicines Corp | Michael Landsittel | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 95.00 per share. | 28 Mar 2024 | 5,000 | 47,286 (0%) | 0% | 95 | 475,000 | Common Stock |
| Blueprint Medicines Corp | Michael Landsittel | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Mar 2024 | 5,000 | 15,000 | - | - | Stock Option (Right to Buy) | |
| Blueprint Medicines Corp | Michael Landsittel | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 36.05 per share. | 15 Mar 2024 | 5,000 | 61,020 (0%) | 0% | 36.1 | 180,250 | Common Stock |
| Blueprint Medicines Corp | Michael Landsittel | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 87.09 per share. | 15 Mar 2024 | 4,629 | 51,391 (0%) | 0% | 87.1 | 403,140 | Common Stock |
| Blueprint Medicines Corp | Michael Landsittel | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 87.10 per share. | 15 Mar 2024 | 2,675 | 58,345 (0%) | 0% | 87.1 | 232,993 | Common Stock |
| Blueprint Medicines Corp | Michael Landsittel | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 88.94 per share. | 15 Mar 2024 | 2,467 | 47,286 (0%) | 0% | 88.9 | 219,415 | Common Stock |
| Blueprint Medicines Corp | Michael Landsittel | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 88.08 per share. | 15 Mar 2024 | 1,638 | 49,753 (0%) | 0% | 88.1 | 144,275 | Common Stock |
| Blueprint Medicines Corp | Michael Landsittel | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 88.27 per share. | 15 Mar 2024 | 1,413 | 56,932 (0%) | 0% | 88.3 | 124,726 | Common Stock |
| Blueprint Medicines Corp | Michael Landsittel | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 88.88 per share. | 15 Mar 2024 | 912 | 56,020 (0%) | 0% | 88.9 | 81,059 | Common Stock |
| Blueprint Medicines Corp | Michael Landsittel | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 90.69 per share. | 07 Mar 2024 | 5,003 | 56,020 (0%) | 0% | 90.7 | 453,722 | Common Stock |
| Blueprint Medicines Corp | Michael Landsittel | CHIEF FINANCIAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2024 | 25,000 | 25,000 | - | - | Stock Option (Right to Buy) | |
| Blueprint Medicines Corp | Michael Landsittel | CHIEF FINANCIAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2024 | 12,500 | 61,023 (0%) | 0% | 0 | Common Stock | |
| Blueprint Medicines Corp | Michael Landsittel | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 45.72 per share. | 06 Mar 2023 | 2,911 | 48,619 (0%) | 0% | 45.7 | 133,091 | Common Stock |
| Blueprint Medicines Corp | Michael Landsittel | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 44.48 per share. | 06 Mar 2023 | 96 | 48,523 (0%) | 0% | 44.5 | 4,270 | Common Stock |
| Blueprint Medicines Corp | Michael Landsittel | CHIEF FINANCIAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2023 | 25,000 | 25,000 | - | - | Stock Option (Right to Buy) | |
| Blueprint Medicines Corp | Michael Landsittel | CHIEF FINANCIAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2023 | 12,500 | 51,530 (0%) | 0% | 0 | Common Stock | |
| Blueprint Medicines Corp | Michael Landsittel | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 60.27 per share. | 03 Mar 2022 | 1,328 | 40,077 (0%) | 0% | 60.3 | 80,039 | Common Stock |
| Blueprint Medicines Corp | Michael Landsittel | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 56.19 per share. | 03 Mar 2022 | 1,047 | 39,030 (0%) | 0% | 56.2 | 58,831 | Common Stock |
| Blueprint Medicines Corp | Michael Landsittel | CHIEF FINANCIAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2022 | 25,000 | 25,000 | - | - | Stock Option (Right to Buy) | |
| Blueprint Medicines Corp | Michael Landsittel | CHIEF FINANCIAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2022 | 12,500 | 41,405 (0%) | 0% | 0 | Common Stock | |
| Blueprint Medicines Corp | Michael Landsittel | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 86.61 per share. | 04 Mar 2021 | 1,411 | 28,905 (0%) | 0% | 86.6 | 122,207 | Common Stock |
| Blueprint Medicines Corp | Michael Landsittel | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 88.98 per share. | 04 Mar 2021 | 96 | 30,316 (0%) | 0% | 89.0 | 8,542 | Common Stock |
| Blueprint Medicines Corp | Michael Landsittel | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2021 | 26,125 | 26,125 | - | - | Stock Option (Right to Buy) | |
| Blueprint Medicines Corp | Michael Landsittel | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2021 | 13,062 | 30,412 (0%) | 0% | 0 | Common Stock |